What We Can Learn from the Elite Controllers

What We Can Learn from the ELITE CONTROLLERS Infected nonprogressors are providing clues to the control, and potentially the eradication, of HIV By Gail Dutton FEATURE ARTICLES 25 Years with HIV ARTICLE EXTRAS Jeff Getty: Lessons in desperate measuresHow a risky experiment led to a new understanding of HIV HIV Shows ItselfA 1981 report in the MMWR marks the beginning The Impact of HIVIts progressions, 1981-2006 and beyond Why Monkeys Block HIVOld world monkeys don't

Written byGail Dutton
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Infected nonprogressors are providing clues to the control, and potentially the eradication, of HIV

Down the near-silent, butterscotch-orange hallways of San Francisco General Hospital's (SFGH) clinic is a waiting room populated by a handful of the poor and indigent. Inside a nearby treatment room a Hispanic mother with a drip line chats with her children. In the lull as clinicians take lunch, Steven G. Deeks points out two nondescript examining rooms: "These two rooms were, essentially, the [world's] first HIV clinic."

Today's calm is a far cry from the late 1980s and early 1990s, when these rooms were the front line in an epidemic that infected a quarter of the gay men in San Francisco. In those days, these halls teemed with people seeking rescue from near-certain death. The sense of desperation was palpable.

Skip Ordway, who has a checkup with Deeks ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies